VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 355 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2013. The put-call ratio across all filers is 0.61 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $171,000 | -40.8% | 11,763 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $289,000 | -21.3% | 11,763 | -35.5% | 0.00% | -33.3% |
| Q2 2016 | $367,000 | -25.7% | 18,238 | 0.0% | 0.01% | -25.0% |
| Q1 2016 | $494,000 | -73.4% | 18,238 | 0.0% | 0.01% | -69.2% |
| Q4 2015 | $1,854,000 | -64.7% | 18,238 | -38.0% | 0.03% | -62.9% |
| Q3 2015 | $5,251,000 | -21.3% | 29,438 | -2.0% | 0.07% | -4.1% |
| Q2 2015 | $6,673,000 | +8.2% | 30,038 | -3.2% | 0.07% | +14.1% |
| Q1 2015 | $6,165,000 | -0.4% | 31,038 | -28.2% | 0.06% | 0.0% |
| Q4 2014 | $6,188,000 | -47.4% | 43,238 | -51.8% | 0.06% | -48.0% |
| Q3 2014 | $11,764,000 | +84.4% | 89,664 | +77.2% | 0.12% | +98.4% |
| Q2 2014 | $6,381,000 | +109.6% | 50,592 | +119.0% | 0.06% | +106.7% |
| Q1 2014 | $3,045,000 | -16.6% | 23,100 | -25.7% | 0.03% | -16.7% |
| Q4 2013 | $3,651,000 | +12.5% | 31,100 | 0.0% | 0.04% | +5.9% |
| Q3 2013 | $3,245,000 | +21.2% | 31,100 | 0.0% | 0.03% | +17.2% |
| Q2 2013 | $2,677,000 | – | 31,100 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |